|1.||Nozue, Tsuyoshi: 2 articles (02/2010 - 06/2008)|
|2.||Michishita, Ichiro: 2 articles (02/2010 - 06/2008)|
|3.||Dallinga-Thie, Geesje M: 2 articles (01/2010 - 12/2008)|
|4.||Hirano, Tsutomu: 2 articles (11/2008 - 06/2008)|
|5.||Doi, K: 2 articles (09/2001 - 12/2000)|
|6.||Sakai, M: 2 articles (09/2001 - 12/2000)|
|7.||Nagasaka, S: 2 articles (09/2001 - 12/2000)|
|8.||Tokuyama, K: 2 articles (09/2001 - 12/2000)|
|9.||Nakai, Y: 2 articles (09/2001 - 12/2000)|
|10.||Fukushima, M: 2 articles (09/2001 - 12/2000)|
|1.||Chronic Kidney Failure (Chronic Renal Failure)
05/01/2000 - "Thus, the aim of the present study was to compare remnant-like particle-cholesterol (RLP-C) in type 2 diabetic and ESRD patients with age- and gender-matched controls. "
05/01/2000 - "Remnant-like particle-cholesterol concentrations in patients with type 2 diabetes mellitus and end-stage renal disease."
09/01/2002 - "We investigated the relationship between insulin-resistance (IR) and remnant-like particle cholesterol (RLP-C) using 472 subjects (174 men and 298 women) randomly selected from inhabitants of two rural communities in Japan, Tanno and Sobetsu. "
09/01/2002 - "Relationship between insulin-resistance and remnant-like particle cholesterol."
12/01/2008 - "Fasting and postprandial remnant-like particle cholesterol concentrations in obese participants are associated with plasma triglycerides, insulin resistance, and body fat distribution."
10/01/2007 - "The serum amyloid A protein (SAA) was higher in SLE patients in the premenopausal state (p=0.025), while remnant like particle-cholesterol (RLP-C), the homeostasis model assessment of insulin resistance (HOMA-IR), and SAA were significantly increased in postmenopausal SLE patients (p=0.001, p<0.001 and p<0.05, respectively). "
09/01/2003 - "Multiple regression analysis showed that remnant-like particle cholesterol, fasting blood sugar and insulin resistance were independent factors for U-8-iso-PGF2 alpha concentration (p < 0.0001, p = 0.0007, p = 0.02). "
06/01/2010 - "Linear regression analysis identified the presence of diabetes mellitus (DM) and PV at baseline as inhibiting factors, and serum remnant-like particle-cholesterol level at baseline as a significant factor significantly affecting the degree of plaque regression. "
05/01/1998 - "We measured serum of remnant-like particle cholesterol (RLP-C) concentrations, and investigated the effects of EPA on serum RLP-C concentrations in patients with diabetes mellitus. "
02/01/1998 - "[Circadian changes in remnant-like particle-cholesterol (RLP-C), and its diagnostic value for postprandial increase in remnant lipoprotein in diabetes mellitus]."
|4.||Cardiovascular Diseases (Cardiovascular Disease)
11/01/2008 - "Remnant-like particle-cholesterol (RLP-C) is recognized as a risk factor for cardiovascular disease. "
01/01/2008 - "Plasma remnant-like particle-cholesterol (RLP-C) and the RBC (n-3) index are novel risk factors for cardiovascular disease. "
03/01/2005 - "A recently developed assay for quantification of remnant-like particle cholesterol has provided considerable evidence that reinforces the concept that elevated levels of plasma remnants are associated with increased cardiovascular disease in different populations and distinct patient groups. "
01/01/1997 - "Recently, involvement of remnant-like particle cholesterol (RLP-C) in atherosclerosis was reported, but this parameter has not been adequately investigated in hemodialysis (HD) patients. "
01/01/2001 - "We tested this hypothesis by quantifying the plasma concentration of remnant-like particle cholesterol (RLP-C) in a cohort of healthy 50-year-old men in whom the common carotid artery intima-media thickness (CCA-IMT) was assessed by B-mode ultrasound as a surrogate marker for atherosclerosis. "
|1.||Renal Dialysis (Hemodialysis)